Form 4: Anixa Biosciences Director Arnold Baskies Purchases Additional Shares

Anixa Biosciences Inc. Director Arnold M. Baskies acquired 5,000 shares of common stock at $3.39 per share, increasing his beneficial ownership to 125,000 shares.

Summary

• Arnold M. Baskies, a Director of Anixa Biosciences Inc. (ANIX), purchased 5,000 shares of the company's common stock.
• The transaction occurred on July 18, 2025, with shares acquired at a price of $3.39 per share.
• Following this purchase, Mr. Baskies beneficially owns a total of 125,000 shares of Anixa Biosciences common stock.
• The filing indicates this transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The purchase of shares by a director is generally a positive signal, indicating confidence in the company's future performance and valuation.

Positives

• A director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The acquisition increases the director's alignment with shareholder interests.

Future Outlook

The document does not provide specific forward-looking statements or guidance beyond the transaction details.

Industry Context

Insider purchases, particularly by directors, are often viewed positively by the market as they suggest management's belief in the company's intrinsic value, which is a common signal across various industries.

Comparison to Industry Standards

• Insider buying activity, such as this director's purchase, is a common indicator of management confidence, aligning with practices observed in other biotechnology and pharmaceutical companies where leadership often invests personally in their firms.
• The transaction price of $3.39 per share provides a benchmark for recent insider valuation of Anixa Biosciences' stock, which can be compared to market prices and analyst targets for similar small-cap biotech firms.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive sign, potentially increasing confidence in the company's stock.
• The transaction reinforces the alignment of the director's financial interests with those of other shareholders.

Key Dates

Recommendation

Keywords

Anixa Biosciences, ANIX, SEC Form 4, Insider Trading, Stock Purchase, Director, Beneficial Ownership, Equity Securities, Rule 10b5-1